“This process has been arduous and taxing, and we still owe significantly more than we have left to collect,” the memo said.
Raising funds is becoming increasingly difficult for California’s cannabis industry, where the illicit market has grown, retail has shrunk and advocates are pushing for fairer taxation rates.
Ascend operates in Illinois, Michigan, Ohio, Massachusetts and New Jersey.
Those who don’t support the bill cite a lack of clinical evidence supporting the efficacy of medical cannabis.
Based on data from the German National Association of Statutory Health Insurance Funds, sales of medical cannabis in Germany have “stagnated,” reports Prohibition Partners.